Nucala (mepolizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** MEPOLIZUMAB

**Strength:** 100 mg/mL

**Dosage form:** Injection, Powder, For Solution

**Route:** Subcutaneous

**Labeler:** GlaxoSmithKline LLC

**Marketing category:** BLA (BLA125526)

**Pharmacologic class:** Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]